Ashleigh Palmer, Provention Bio CEO

With FDA de­ci­sion one month away, Proven­tion part­ners with Sanofi on US mar­ket­ing for type 1 di­a­betes drug

Though its FDA de­ci­sion is one month away, Proven­tion Bio has al­ready be­gun its com­mer­cial ef­forts for its type 1 di­a­betes drug — and it’s now …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.